Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis

Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis

Show other versions (1)

<h4>Introduction</h4> 2021 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Reports recommends that patients with clinically significant symptoms and exacerbations of chronic obstructive pulmonary disease (COPD) should escalate to triple therapy, a combined use of inhaled co...

Full description

Bibliographic Details
Main Authors:	Yixuan Jiang, Hao Hu, Siu-wai Leung
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341520/?tool=EBI

Similar Items

Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis.
by: Yixuan Jiang, et al.
Published: (2021-01-01)

Current appraisal of single inhaler triple therapy in COPD
by: Lipworth B, et al.
Published: (2018-09-01)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
by: Bourbeau J, et al.
Published: (2021-03-01)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
by: Claudia C. Dobler
Published: (2018-12-01)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
by: Ian Naya, et al.
Published: (2018-10-01)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
by: Emanuela Resta, et al.
Published: (2022-10-01)

Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
by: Suissa S, et al.
Published: (2022-08-01)

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
by: Elisabeth Fenwick, et al.
Published: (2021-03-01)

Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial
by: Alan Martin, et al.
Published: (2022-02-01)

Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity
by: Sophia Eilat-Tsanani, et al.
Published: (2024-12-01)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
by: Ismaila AS, et al.
Published: (2019-11-01)

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
by: David M.G. Halpin, et al.
Published: (2021-06-01)

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
by: Paly VF, et al.
Published: (2022-12-01)

Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England
by: Rothnie KJ, et al.
Published: (2022-06-01)

The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Chih-Cheng Lai, et al.
Published: (2022-01-01)

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial
by: Sundeep Salvi, et al.
Published: (2021-07-01)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
by: López-Campos JL, et al.
Published: (2020-07-01)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
by: Gerard Criner, et al.
Published: (2023-01-01)

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
by: Halpin DM, et al.
Published: (2022-10-01)

The Effects Of Single Inhaler Triple Therapy Vs Single Inhaler Dual Therapy Or Separate Triple Therapy For The Management Of Chronic Obstructive Pulmonary Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials [Corrigendum]
by: Lai CC, et al.
Published: (2020-01-01)

Single Inhaler LABA/LAMA for COPD
by: Mario Malerba, et al.
Published: (2019-04-01)

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
by: Abdul Aziz MI, et al.
Published: (2018-10-01)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
by: Kiff C, et al.
Published: (2018-09-01)

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study
by: Sicras-Mainar A, et al.
Published: (2020-12-01)

When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals
by: Gaduzo S, et al.
Published: (2019-02-01)

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
by: Helgo Magnussen, et al.
Published: (2021-01-01)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01)

Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study
by: Gessner C, et al.
Published: (2022-12-01)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
by: Sandeep Bansal, et al.
Published: (2021-05-01)

Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD
by: Miravitlles M, et al.
Published: (2020-07-01)

Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
by: Ling Lin, et al.
Published: (2023-03-01)

Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
by: Huanyu Long, et al.
Published: (2021-07-01)

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
by: Sue Langham, et al.
Published: (2019-11-01)

Comparative efficacy of inhalers in mild-to-moderate asthma: systematic review and network meta-analysis
by: Hyung Jun Park, et al.
Published: (2022-04-01)

Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score
by: Paola Rogliani, et al.
Published: (2022-08-01)

A randomized, open-label, single-visit crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD
by: van der Palen J, et al.
Published: (2018-08-01)

Inhaled therapy reduces COPD mortality
by: Stefan Andreas, et al.
Published: (2020-11-01)

Improving adherence with inhaler therapy in COPD
by: Suzanne C Lareau, et al.
Published: (2010-11-01)

Inhaled corticosteroids in COPD.
by: Brightling, C, et al.
Published: (1999)

Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
by: Efthymia Papadopoulou, et al.
Published: (2024-03-01)